Efficacy and Safety of Ilaprazole for GERD: A Randomized,Double-Blind, Esomeprazole-Controlled,Phase2,Multicenter Trial in China.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Ilaprazole (Primary) ; Esomeprazole
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Sponsors Livzon Group
- 07 Sep 2016 Primary endpoint (The proportion of patients with healed esophagitis at week 8) has not been met ,according to the results published in the Clinical Drug Investigation .
- 07 Sep 2016 Results published in the Clinical Drug Investigation (2016).
- 22 Apr 2010 New trial record